BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25622566)

  • 1. Analysis of circulating tumor cells derived from advanced gastric cancer.
    Toyoshima K; Hayashi A; Kashiwagi M; Hayashi N; Iwatsuki M; Ishimoto T; Baba Y; Baba H; Ohta Y
    Int J Cancer; 2015 Aug; 137(4):991-8. PubMed ID: 25622566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of intraperitoneal CD44 mRNA levels of magnetically separated CD45-negative EpCAM-positive cells for peritoneal recurrence and prognosis in stage II and III gastric cancer patients.
    Horikawa M; Iinuma H; Inoue T; Ogawa E; Fukushima R
    Oncol Rep; 2011 May; 25(5):1413-20. PubMed ID: 21331451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas.
    Kubisch I; de Albuquerque A; Schuppan D; Kaul S; Schaich M; Stölzel U
    Oncology; 2015; 89(5):294-303. PubMed ID: 26315108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating CEA-positive and EpCAM-negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancer.
    Miki Y; Yashiro M; Kuroda K; Okuno T; Togano S; Masuda G; Kasashima H; Ohira M
    Cancer Med; 2021 Jan; 10(2):521-528. PubMed ID: 33381922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
    Hyun KA; Lee TY; Lee SH; Jung HI
    Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in the enumeration and phenotyping of CTC.
    Coumans FA; Ligthart ST; Uhr JW; Terstappen LW
    Clin Cancer Res; 2012 Oct; 18(20):5711-8. PubMed ID: 23014524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44v8-10 is a cancer-specific marker for gastric cancer stem cells.
    Lau WM; Teng E; Chong HS; Lopez KA; Tay AY; Salto-Tellez M; Shabbir A; So JB; Chan SL
    Cancer Res; 2014 May; 74(9):2630-41. PubMed ID: 24618343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
    Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
    Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
    Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
    Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry.
    Pituch-Noworolska A; Wieckiewicz J; Krzeszowiak A; Stachura J; Ruggiero I; Gawlicka M; Szczepanik A; Karcz D; Popiela T; Zembala M
    Anticancer Res; 1998; 18(5B):3747-52. PubMed ID: 9854488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation.
    Wang N; Shi L; Li H; Hu Y; Du W; Liu W; Zheng J; Huang S; Qu X
    Tumour Biol; 2012 Apr; 33(2):561-9. PubMed ID: 22241087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
    Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
    World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of circulating tumor cells from human gastric cancer patients.
    Yuan D; Chen L; Li M; Xia H; Zhang Y; Chen T; Xia R; Tang Q; Gao F; Mo X; Liu M; Bi F
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):647-60. PubMed ID: 25326346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44
    Szczepanik A; Sierzega M; Drabik G; Pituch-Noworolska A; Kołodziejczyk P; Zembala M
    Gastric Cancer; 2019 Mar; 22(2):264-272. PubMed ID: 30056567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.